Table 3.
Charles et al,47 2008 (N = 885) |
Johansson et al,7 2010 (N = 184) |
Johnstone et al,8 2008 (N = 193) |
Lieberman et al,9 2010 (N = 183) |
Jennings et al,6 2008 (N = 225)a |
Templeton et al,48 2005 (N = 105) |
|
---|---|---|---|---|---|---|
Age | Not stated | Mean 63 | Median 71 | Mean 60 | Median 70 | Median 60 |
Any pathogen | 46% | 67% | 39% | Not stated | 58% | 76% |
Any bacteria | 38% | 58%b | 20% | Not stated | 48% | 46% |
Any virus | 15% | 29% | 15% | 32% | 34% | 54% |
Coinfection | 9% | 23% | 4% | Not stated | 30% | 27% |
RSV | 2% | 4% | 3% | 7% | 4% | 3% |
Influenza virus | 8% | 8% | 4% | 4% | 12% | 10% |
hMPV | NS | 2% | 4% | 1% | 0% | 0% |
Adenovirus | <1% | 2% | 1% | 2% | 4% | 4% |
Parainfluenza virus | <1% | 4% | 2% | 0% | 1% | 8% |
Rhinovirus/enterovirusc | 5% | 7% | 2% | 5% | 13% | 17% |
Coronavirus | NS | 2% | 2% | 13% | 2% | 13% |
Abbreviation: NS, not sought.
Includes those with complete viral testing.
PCR assays were used for bacterial pathogens including Streptococcus pneumoniae, Haemophilus influenza, Moraxella, Legionella sp, Mycoplasma pneumoniae, and Chlamydophila pneumoniae.
Most assays identify both rhinovirus and enterovirus.